Table of Contents:
  • Overview of Drug Development
  • Overview of the Role of Pathology in Product Discovery and Development
  • Discovery Toxicology and Discovery Pathology
  • Pathology in Nonclinical Drug Safety Assessment
  • Carcinogenicity Assessment
  • Protein Therapeutics
  • Nucleic Acid Pharmaceutical Agents
  • Gene Therapy and Gene Editing
  • Vaccines
  • Stem Cell and Other Cell Therapies
  • Biomedical Materials and Devices
  • Safety Assessment of Agricultural and Bulk Chemicals
  • Preparation of the Anatomic Pathology Report for Toxicity Studies
  • Interpretation of Clinical Pathology Results in Nonclinical Toxicity Testing
  • Assigning Adversity to Toxicologic Outcomes
  • Risk Assessment
  • Risk Management and Communication: Building Trust and Credibility With the Public.